Liposarcoma: all 144 studies
Page 2 of 2. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.
- Patient Reported Outcome Measures (PROMs) With TrabectedinTerminatedNCT03959033
- Selinexor in Combination With Ixazomib for the Treatment of Advanced SarcomaWithdrawnNCT03880123Phase 1
- Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)Status unknownNCT03816475Phase 2
- A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or LeiomyosarcomaCompletedNCT03810976Phase 2
- Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With TrabectedinWithdrawnNCT03773510Phase 3
- APX005M and Doxorubicin in Advanced SarcomaCompletedNCT03719430Phase 2
- Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasTerminatedNCT03670069Phase 1
- Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallStatus unknownNCT03651375Phase 2
- Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsTerminatedNCT03604783Phase 1
- Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasActive, not recruitingNCT03600649Phase 1
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent SarcomaCompletedNCT03450122Phase 1
- NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)TerminatedNCT03399448Phase 1
- Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable SarcomaWithdrawnNCT03397186Phase 2
- Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by SurgeryActive, not recruitingNCT03361436Phase 1
- Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before SurgeryActive, not recruitingNCT03307616Phase 2
- The FGF/FGFR Signalling Pathway:CompletedNCT03303885
- Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Active, not recruitingNCT03114527Phase 2
- A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaStatus unknownNCT03096912Phase 2
- Retrospective Evaluation of LiposarcomaCompletedNCT03034252
- Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryCompletedNCT03009201Phase 1
- Detection of Circulating Tumor Cells in Patients With SarcomasStatus unknownNCT02983539
- Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by SurgeryActive, not recruitingNCT02923778Phase 2
- Study of Abemaciclib in Dedifferentiated LiposarcomaActive, not recruitingNCT02846987Phase 2
- Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaCompletedNCT02821507Phase 2
- Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of RetroperitoneumStatus unknownNCT02587169Phase 1/2
- A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaStatus unknownNCT02571829Phase 2
- Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With LiposarcomaCompletedNCT02343172Phase 1
- Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated LiposarcomaCompletedNCT02247544Phase 2
- Dose Reduction of Preoperative Radiotherapy in Myxoid LiposarcomasStatus unknownNCT02106312Phase 2
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaWithdrawnNCT02059850Phase 1
- Ph II Cabazitaxel DD LiposarcomaCompletedNCT01913652Phase 2
- A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or LeiomyosarcomaCompletedNCT01692678Phase 3
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
- A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and LiposarcomaCompletedNCT01537744Phase 1
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01477021Phase 1
- Combination Therapy of Gemcitabine and Trabectedin in L-sarcomasCompletedNCT01426633Phase 1
- A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking SurgeryCompletedNCT01143740Phase 1
- Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated LiposarcomaWithdrawnNCT00969917Phase 2
- Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
- Brostallicin Clinical Trial for Myxoid LiposarcomaStatus unknownNCT00633165Phase 2
- An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
- Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)CompletedNCT00093080Phase 2
- Rosiglitazone in Treating Patients With LiposarcomaCompletedNCT00004180Phase 2
- Troglitazone in Treating Patients With LiposarcomaCompletedNCT00003058Phase 2